| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 16.936 | 15.846 | 14.129 | 12.051 | 12.718 | 13.546 | 14.415 | 14.518 | 15.756 | 13.884 |
| Total Income - EUR | 16.937 | 15.846 | 14.130 | 12.052 | 12.719 | 13.547 | 15.759 | 14.621 | 15.760 | 13.884 |
| Total Expenses - EUR | 9.160 | 10.172 | 5.418 | 4.916 | 5.106 | 7.162 | 10.096 | 10.311 | 17.471 | 10.745 |
| Gross Profit/Loss - EUR | 7.776 | 5.674 | 8.713 | 7.137 | 7.613 | 6.385 | 5.663 | 4.310 | -1.711 | 3.140 |
| Net Profit/Loss - EUR | 7.268 | 5.199 | 8.289 | 6.775 | 7.232 | 6.012 | 5.200 | 3.880 | -2.005 | 2.305 |
| Employees | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Crigomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 589 | 478 | 385 | 0 | 0 | 584 | 861 | 169 | 0 | 0 |
| Current Assets | 25.427 | 10.132 | 17.879 | 22.721 | 29.941 | 33.834 | 12.767 | 13.073 | 10.892 | 12.154 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3.636 | 4.580 | 4.320 | 3.781 | 2.541 | 6.334 | 7.933 | 854 | 2.558 | 1.924 |
| Cash | 21.791 | 5.552 | 13.559 | 18.940 | 27.400 | 27.500 | 4.834 | 12.219 | 8.334 | 10.230 |
| Shareholders Funds | 25.950 | 8.617 | 16.759 | 23.227 | 30.009 | 35.453 | 17.630 | 14.468 | 10.499 | 11.540 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 943 | 1.993 | 1.505 | 1.315 | 2.233 | 837 | 333 | 492 | 393 | 613 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Crigomed Srl